---
figid: PMC9187215__nihms-1756839-f0002
pmcid: PMC9187215
image_filename: nihms-1756839-f0002.jpg
figure_link: /pmc/articles/PMC9187215/figure/F2/
number: 'Figure 2:'
figure_title: ''
caption: 'Potential druggable targets in the interferon pathway for treatment of systemic
  sclerosis include the following: (I) plasmacytoid dendritic cells; (II) interferon-α/β
  receptor (IFNAR); (III) JAK/STATs; (IV) Interferon regulatory factors (IRF).'
article_title: 'Dysregulation of Type 1 Interferon Signaling in Systemic Sclerosis:
  a Promising Therapeutic Target?.'
citation: Minghua Wu, et al. Curr Treatm Opt Rheumatol. ;7(4):349-360.
year: '2023'

doi: 10.1007/s40674-021-00188-9
journal_title: Current treatment options in rheumatology
journal_nlm_ta: Curr Treatm Opt Rheumatol
publisher_name: ''

keywords:
- Systemic sclerosis
- Type I interferon
- Treatment

---
